Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Cancer Research|June 5, 2007
Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profilesKenji Tamura, Mutsuo Furihata, Tatsuhiko Tsunoda, et al.Life Science Alliance|July 24, 2019
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticityYuko Matsumura, Yasuhiko Ito, Yoshihiro Mezawa, et al.Journal of Medicinal Chemistry|January 28, 2015
Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activityKen-Ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.Bioorganic & Medicinal Chemistry|March 25, 2015
A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activityKen-ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.Journal of Medicinal Chemistry|May 3, 2013
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)Ken-ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.Journal of the National Cancer Institute|December 26, 2022
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosisYoko Matsuda, Juanjuan Ye, Keiko Yamakawa, et al.Nature Communications|April 8, 2026
Establishment of DNA methylation during primate germ cell developmentKazuaki Kojima, Yi Li, Shin-Ichi Tomizawa, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformationKen-Ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.The Journal of Pathology|January 30, 2022
Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organsYoko Matsuda, Taro Yamashita, Juanjuan Ye, et al.Nature Communications|August 10, 2016
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinomaKouya Shiraishi, Yukinori Okada, Atsushi Takahashi, et al.Pageof 16